In modern psychiatry, many people don’t come in taking one medication — they come in taking three, four, sometimes six or more. Antidepressants layered with mood stabilizers, antipsychotics added “just in case,” sleep medications that never got revisited, and PRNs that quietly became daily habits.
This practice is known as psychiatric polypharmacy — the use of multiple psychotropic medications at the same time.
Sometimes polypharmacy is appropriate and lifesaving.
But often, it’s a sign that medications were added over time without a clear plan to reassess or remove them.
New research is finally catching up to what many patients and clinicians have been feeling for years: more medication does not always mean better care — and thoughtful deprescribing can improve both outcomes and quality of life.
What Is Psychiatric Polypharmacy?
Polypharmacy typically refers to taking two or more psychiatric medications, often from different classes, such as:
- Antidepressants
- Antipsychotics
- Mood stabilizers
- Benzodiazepines
- Sleep medications
- Stimulants
While some combinations are evidence-based, others persist simply because:
- Symptoms changed
- A medication “sort of helped”
- Side effects were treated with another medication
- Time was limited
- No one paused to reassess the full picture
Over time, this can lead to overmedication, increased side effects, and confusion about what’s actually helping.
What the New Research Shows
A 2025 study published in BMC Psychiatry examined psychiatric polypharmacy in adult outpatients and explored patients’ attitudes toward deprescribing.
Key findings:
- Nearly 1 in 3 patients were taking multiple psychotropic medications
- Many reported feeling burdened by side effects, cost, or complexity
- A significant number were open to deprescribing if it was done safely and collaboratively
This matters — because it challenges the assumption that patients want to stay on large medication regimens indefinitely.
Patients are often waiting for someone to ask:
“Do we still need all of this?”
Why Polypharmacy Can Become a Problem
Psychiatric polypharmacy can increase the risk of:
- Sedation and cognitive fog
- Emotional blunting
- Weight gain and metabolic changes
- Sexual side effects
- Falls and injuries (especially in older adults)
- Drug–drug interactions
- Difficulty identifying which medication is helping or harming
A 2024 narrative review on psychiatric deprescribing highlights that many patients remain on medications long after the original indication has resolved, simply because stopping feels risky or unclear.
But staying on unnecessary medications also carries risk.
What Is Deprescribing (and What It Is Not)?
Deprescribing is not “giving up on treatment.”
It is a deliberate, evidence-informed process of:
- Reassessing the original purpose of each medication
- Evaluating ongoing benefit vs. harm
- Slowly reducing or discontinuing medications that no longer serve the patient
Good deprescribing is:
- Collaborative
- Gradual
- Monitored
- Reversible if needed
It’s about simplifying care, not abandoning it.
Who Benefits Most from Deprescribing?
Research shows deprescribing can be especially helpful for:
- People with long medication histories
- Older adults
- Individuals experiencing side effects without clear benefit
- Patients with treatment-resistant symptoms
- Those feeling “numb,” foggy, or disconnected
- Anyone unsure which medication is doing what
A 2024 geriatric psychiatry study found that deprescribing was both feasible and beneficial in older adults, with many patients successfully reducing at least one psychotropic medication without symptom worsening.
Why Deprescribing Is Hard (But Worth It)
Deprescribing doesn’t happen easily because:
- Withdrawal symptoms can mimic relapse
- Clinicians fear destabilizing patients
- Time pressures limit careful medication review
- Patients worry about “going backward”
But newer studies — including a 2025 analysis of pharmacist involvement — show that team-based, thoughtful deprescribing improves confidence and outcomes.
This reinforces something we value deeply at Ania-Ra:
psychiatric care works best when it is collaborative, intentional, and paced.
How Safe Deprescribing Actually Happens
Safe deprescribing typically includes:
- A full medication review
Why was each medication started? Is that reason still present? - Identifying low-value or duplicative medications
Especially PRNs that became daily or add-on medications without reassessment. - One change at a time
This allows the nervous system to adjust and helps clarify cause and effect. - Slow tapers, not abrupt stops
Particularly with benzodiazepines, antidepressants, and antipsychotics. - Ongoing monitoring and support
Including sleep, mood, anxiety, and functioning.
Deprescribing is not rushed — and it should never feel punitive or dismissive.
What This Means for Patients
If you’re taking multiple psychiatric medications and wondering:
- Do I need all of these?
- Why am I still on this medication?
- Could fewer medications actually help me feel clearer?
You’re asking very reasonable questions — and current research supports having that conversation.
You deserve care that evolves with you.
The Ania-Ra Psychiatry Perspective
At Ania-Ra Psychiatry, we approach medication with humility, curiosity, and respect for the nervous system.
That means:
- Prescribing thoughtfully
- Avoiding unnecessary polypharmacy
- Revisiting medications regularly
- Supporting safe deprescribing when appropriate
- Integrating therapy, lifestyle, trauma-informed care, and whole-body health
More medication is not always better care.
Sometimes, less is more — when done carefully.
Final Thoughts
Psychiatric polypharmacy is common — but it shouldn’t be automatic or permanent.
New research confirms what many patients already know in their bodies: simpler, intentional treatment can be safer and more effective.
Deprescribing isn’t about taking something away.
It’s about making room for clarity, agency, and healing.
Sources
Psychotropic polypharmacy and attitudes toward deprescribing (2025), BMC Psychiatry
https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-025-06746-y
Psychiatric deprescribing: A narrative review (2024)
https://pubmed.ncbi.nlm.nih.gov/37392084/
Deprescribing psychotropic medications in older adults (2024)
https://www.ggaging.com/export-pdf/1821/v18e0000043.pdf
Polypharmacy and deprescribing — JAMA Patient Page
https://jamanetwork.com/journals/jama/fullarticle/2808052
Maudsley Prescribing Guidelines — Deprescribing principles
https://www.maudsley-prescribing-guidelines.co.uk/
